Ticker
GALTCompany Name
GALECTIN THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Issuance (Repayment) of Debt Securities | Net Cash Flow - Dividends & Other Cash Distributions | Shareholder Yield |
---|---|---|---|---|---|
6/30/2025 | $ 240.87M | $ 2.79M | $ 21M | $ 0 | -9.88% |
3/31/2025 | $ 83.54M | $ 1.23M | $ 20M | $ 0 | -25.41% |
12/31/2024 | $ 77.08M | $ 1.23M | $ 30M | $ 0 | -40.51% |
9/30/2024 | $ 172.6M | $ 376K | $ 40M | $ 0 | -23.39% |
6/30/2024 | $ 140.13M | $ 10.41M | $ 30M | $ 0 | -28.84% |
3/31/2024 | $ 190.17M | $ 10.03M | $ 30M | $ 0 | -21.05% |
12/31/2023 | $ 147.95M | $ 10.03M | $ 30M | $ 0 | -27.06% |
9/30/2023 | $ 120.6M | $ 10.03M | $ 30M | $ 0 | -33.19% |
6/30/2023 | $ 88.78M | $ 0 | $ 30M | $ 0 | -33.79% |
3/31/2023 | $ 97.71M | $ 0 | $ 20M | $ 0 | -20.47% |
(-1 * CF - Equity -1 * CF - Dividends -1 * CF - Debt) / Market Cap
(=) Shareholder Yield
Shareholder Yield for GALECTIN THERAPEUTICS INC is calculated as follows: (-1 * CF - Equity [ $ 1.17M ] -1 * CF - Dividends [ $ 0 ] -1 * CF - Debt [ $ 0 ]) / Market Cap [ $ 143.83M ]
(=) Shareholder Yield [ -0.81% ]
Minimum
Mar 31, 2022
Maximum
Mar 31, 2021
Average
Median
filtered constituents | 3.49K |
---|---|
min | -33.43% |
max | 34.45% |
average | 0.58% |
median | 1.07% |
std | 11.13% |